Literature DB >> 2897085

Muscarinic receptor interaction with full and partial beta-adrenoceptor agonists in the rat colon strip.

B Ek1.   

Abstract

beta-Adrenoceptor agonists inhibit contractile activity in isolated colon strips. In order to demonstrate that beta-adrenoceptors are located at different functional levels within the colon wall, increasing concentrations of muscarinic agonists were used to interact functionally with the beta-adrenoceptor-mediated inhibition of spontaneous colon activity. The effects of the full agonists isoprenaline and terbutaline and of the partial agonist prenalterol were functionally antagonized by carbachol (0.03 and 0.3 mumol/l) and bethanechol (1.3 and 30 mumol/l). This functional antagonism was parallelled by an increase in baseline tension and spontaneous contractile activity of the isolated colon strip. At lower concentrations of carbachol (0.003 and 0.01 mumol/l) or bethanechol (0.03 and 0.3 mumol/l) no effect on the contractile status of the smooth muscle or on the pD2-values of the full agonists was seen. However, at these lower concentrations of muscarinic agonists a marked decrease in the maximal inhibitory response to the partial beta-adrenoceptor agonist prenalterol was demonstrated. The inhibitory response to prenalterol showed a biphasic concentration-response curve. The muscarinic antagonist atropine produced an increase in the maximal response of the high potency component of the concentration-response curve for prenalterol and an increase in the sensitivity to isoprenaline. These results demonstrate the presence of a high cholinergic tone in the colon preparation of a magnitude that clearly reduces the sensitivity to beta-adrenoceptor agonists. The different responses to full and partial beta-adrenoceptor agonists in the presence of increasing concentrations of muscarinic agonists may indicate that beta-adrenoceptors are located on two different functional units within the colon wall.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897085     DOI: 10.1007/bf00169240

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  On the use of functional antagonism to estimate dissociation constants for beta adrenergic receptor agonists in isolated guinea-pig trachea.

Authors:  C K Buckner; R K Saini
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

Review 2.  Neurohumoral, hormonal, and drug receptors for the lower esophageal sphincter.

Authors:  R K Goyal; S Rattan
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

3.  Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique.

Authors:  A A Hancock; A L DeLean; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

4.  Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.

Authors:  H Mattsson; A Hedberg; E Carlsson
Journal:  J Pharmacol Exp Ther       Date:  1983-03       Impact factor: 4.030

5.  Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.

Authors:  T P Kenakin; D Beek
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

6.  Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.

Authors:  B A Ek; L A Bjellin; B T Lundgren
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

7.  Beta-adrenergic control of motility in the rat colon. II. Proportions of beta 1- and beta 2-adrenoceptors identified with 125I-(-)pindolol binding.

Authors:  B A Ek; S R Nahorski
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

8.  Increased beta I-adrenoceptor density after 6-hydroxydopamine pretreatment in rat colon and lung.

Authors:  B Ek; B Lundgren
Journal:  Acta Physiol Scand       Date:  1986-08

9.  Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.

Authors:  B Ek
Journal:  Acta Physiol Scand Suppl       Date:  1985

10.  Characterization of the beta-adrenergic inhibition of motility in cat colon strips.

Authors:  B Ek; B Lundgren
Journal:  Eur J Pharmacol       Date:  1982-01-08       Impact factor: 4.432

  10 in total
  1 in total

Review 1.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.